Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia.

Trial Profile

Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 30 Sep 2016

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Priapism
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Sep 2016 Status changed from discontinued to withdrawn prior to enrolment as trial closed just prior to study receiving Investigational Review Board approval
    • 09 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top